1313408-99-9

Basic information

• Product Name: ethyl 7-fluoroimidazo[1,2-a]pyridine-3-carboxylate
• Synonyms: ethyl 7-fluoroimidazo[1,2-a]pyridine-3-carboxylate;7-Fluoro-imidazo[1,2-a]pyridine-3-carboxylic acid ethyl ester
• CAS NO: 1313408-99-9
• Molecular Formula: C₁₀H₉FN₂O₂
• Molecular Weight: 208.19
• EINECS: -0
• Mol File: 1313408-99-9.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ethyl 7-fluoroimidazo[1,2-a]pyridine-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 7-fluoroimidazo[1,2-a]pyridine-3-carboxylate(1313408-99-9)
• EPA Substance Registry System: ethyl 7-fluoroimidazo[1,2-a]pyridine-3-carboxylate(1313408-99-9)

Safety Data

• Hazardous Substances Data: 1313408-99-9(Hazardous Substances Data)

Upstream product

• 1237535-76-0 4-fluoropyridin-2-ylcarbamic acid tert-butyl ester 
• 34941-91-8 2-chloro-4-fluoropyridine 
• 944401-77-8 4-fluoropyridin-2-amine 
• 33142-21-1 ethyl 2-chloro-3-oxopropanoate 

Downstream Products

• 1159827-76-5 7-fluoroimidazo[1,2-a]pyridine-3-carboxylic acid 

Relevant articles and documents

SPIROCYCLOHEPTANES AS INHIBITORS OF ROCK

The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically-acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.

SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1, 2-A]PYRIDINE-3- CARBOXAMIDE COMPOUNDS AS CFMS INHIBITORS

Compounds of Formula (I): and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4 and R5 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases and pain.